| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 37.65B | 32.97B | 46.43B | -5.71B | 69.59B |
| Gross Profit | 29.92B | 18.42B | 46.43B | 10.86B | 16.83B |
| EBITDA | 6.08B | 6.32B | 4.90B | 5.88B | 6.67B |
| Net Income | 2.63B | 2.79B | 2.25B | 2.25B | 2.97B |
Balance Sheet | |||||
| Total Assets | 925.74B | 851.36B | 749.48B | 733.65B | 661.63B |
| Cash, Cash Equivalents and Short-Term Investments | 34.13B | 27.69B | 21.88B | 22.25B | 8.16B |
| Total Debt | 25.88B | 22.80B | 20.94B | 21.17B | 19.53B |
| Total Liabilities | 880.69B | 807.37B | 708.21B | 689.55B | 617.90B |
| Stockholders Equity | 24.43B | 23.88B | 22.14B | 24.02B | 24.34B |
Cash Flow | |||||
| Free Cash Flow | 4.16B | 5.08B | 4.76B | 6.70B | 10.49B |
| Operating Cash Flow | 4.78B | 5.95B | 5.93B | 7.50B | 11.05B |
| Investing Cash Flow | -348.00M | -1.76B | -2.62B | -6.50B | -10.58B |
| Financing Cash Flow | -3.67B | -1.32B | -2.80B | -948.00M | -962.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | C$18.25B | 13.67 | 13.19% | 3.59% | 17.16% | 22.85% | |
80 Outperform | C$71.19B | 11.83 | 15.17% | 3.62% | 4.22% | 13.75% | |
72 Outperform | C$89.17B | 16.83 | 12.65% | 3.49% | 15.84% | 31.26% | |
71 Outperform | C$51.60B | 27.57 | 10.81% | 3.28% | 19.07% | -3.74% | |
71 Outperform | C$55.53B | 22.52 | 12.98% | 4.11% | -10.77% | -1.88% | |
71 Outperform | C$15.48B | 24.06 | 12.80% | 2.11% | -1.40% | 14.51% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |